PL2306988T3 - Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego - Google Patents

Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego

Info

Publication number: PL2306988T3
Authority: PL; Poland
Prior art keywords: treating; pharmaceutical formulation; digestive tract; upper digestive; antiinflammatory
Prior art date: 2008-07-21

Application number

PL09800023T

Other languages

English (en)

Inventor

Rudolf Wilhelm

Markus Pröls

Original Assignee

Dr Falk Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-21

Filing date

2009-07-02

Publication date

2013-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2306988(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-07-02 Application filed by Dr Falk Pharma Gmbh filed Critical Dr Falk Pharma Gmbh

2013-04-30 Publication of PL2306988T3 publication Critical patent/PL2306988T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

PL09800023T 2008-07-21 2009-07-02 Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego PL2306988T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP08013091A EP2151235B1 (de)	2008-07-21	2008-07-21	Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
PCT/EP2009/058320 WO2010009961A1 (de)	2008-07-21	2009-07-02	Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes
EP09800023A EP2306988B1 (de)	2008-07-21	2009-07-02	Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Publications (1)

Publication Number	Publication Date
PL2306988T3 true PL2306988T3 (pl)	2013-04-30

Family

ID=39951664

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL08013091T PL2151235T3 (pl)	2008-07-21	2008-07-21	Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego
PL09800023T PL2306988T3 (pl)	2008-07-21	2009-07-02	Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL08013091T PL2151235T3 (pl)	2008-07-21	2008-07-21	Preparat farmaceutyczny do leczenia górnego przewodu pokarmowego

Country Status (23)

Country	Link
US (2)	US8580300B2 (pl)
EP (2)	EP2151235B1 (pl)
JP (2)	JP5616889B2 (pl)
CN (1)	CN102159196B (pl)
AT (1)	ATE498396T1 (pl)
AU (1)	AU2009273361B2 (pl)
CA (1)	CA2731312C (pl)
CY (2)	CY1111878T1 (pl)
DE (1)	DE502008002621D1 (pl)
DK (2)	DK2151235T3 (pl)
EA (1)	EA018465B1 (pl)
ES (2)	ES2358158T3 (pl)
HR (2)	HRP20130171T1 (pl)
IL (1)	IL210779A (pl)
ME (2)	ME01256B (pl)
NZ (1)	NZ590593A (pl)
PL (2)	PL2151235T3 (pl)
PT (2)	PT2151235E (pl)
RS (2)	RS51649B (pl)
SI (2)	SI2151235T1 (pl)
UA (1)	UA100759C2 (pl)
WO (1)	WO2010009961A1 (pl)
ZA (1)	ZA201100283B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8895064B2 (en) *	1999-06-14	2014-11-25	Cosmo Technologies Limited	Controlled release and taste masking oral pharmaceutical composition
DE60005819T2 (de)	1999-06-14	2004-05-06	Cosmo S.P.A.	Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2151235B1 (de) *	2008-07-21	2011-02-16	Dr. Falk Pharma Gmbh	Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
CA2765033C (en)	2009-06-12	2020-07-14	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
GEP20156281B (en)	2009-10-01	2015-05-11	Aptalis Pharmatech Inc	Orally administered corticosteroid compositions
US10154964B2 (en)	2011-09-07	2018-12-18	Cosmo Technologies Limited	Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
HRP20190677T4 (hr) *	2013-12-23	2023-02-03	Dr. Falk Pharma Gmbh	Optimizirana farmaceutska formula za liječenje upalnih promjena u jednjaku
TWI777515B (zh)	2016-08-18	2022-09-11	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332394A1 (de)	1993-09-23	1995-03-30	Falk Pharma Gmbh	Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) *	1995-02-03	1997-06-17	Eurand America, Incorporated	Effervescent microcapsules
US5607697A (en) *	1995-06-07	1997-03-04	Cima Labs, Incorporated	Taste masking microparticles for oral dosage forms
US5807578A (en) *	1995-11-22	1998-09-15	Lab Pharmaceutical Research International Inc.	Fast-melt tablet and method of making same
US5807577A (en) *	1995-11-22	1998-09-15	Lab Pharmaceutical Research International Inc.	Fast-melt tablet and method of making same
GB9611364D0 (en) *	1996-05-31	1996-08-07	Smithkline Beecham Plc	Composition
US6350470B1 (en) *	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
JP3818789B2 (ja) *	1999-02-18	2006-09-06	三菱化学フーズ株式会社	易崩壊性錠剤
JP4038772B2 (ja)	2001-07-11	2008-01-30	敏朗関根	光合成微生物の培養方法と装置
CN1578657A (zh) *	2001-09-25	2005-02-09	兰贝克赛实验室有限公司	制备快速溶解剂型的方法
CA2467747A1 (en) *	2001-11-20	2003-05-30	Dmi Biosciences, Inc.	Methods and products for oral care
EP1487419A2 (en) *	2002-03-20	2004-12-22	Elan Pharma International Limited	Fast dissolving dosage forms having reduced friability
SE0401031D0 (sv) *	2004-04-22	2004-04-22	Duocort Ab	A new glucocorticoid replacement therapy
US20060013873A1 (en) *	2004-07-16	2006-01-19	Chih-Chiang Yang	Bioadhesive dosage form of steroids
US20070071817A1 (en) *	2005-09-26	2007-03-29	Phyzz, Inc.	Effervescent oral care compositions and method of use
EP1993598A2 (en) *	2006-02-15	2008-11-26	Tika Läkemedel AB	Methods of manufacturing corticosteroid solutions
DK2170348T3 (en) *	2007-06-22	2016-11-07	Dompé Farm S P A	SHOWER TABLETS for inhalation
EP2205213A2 (en) *	2007-10-01	2010-07-14	Laboratorios Lesvi, S.L.	Orodispersible tablets
EP2151235B1 (de) *	2008-07-21	2011-02-16	Dr. Falk Pharma Gmbh	Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
CA2765033C (en) *	2009-06-12	2020-07-14	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders

2008
- 2008-07-21 EP EP08013091A patent/EP2151235B1/de active Active
- 2008-07-21 AT AT08013091T patent/ATE498396T1/de active
- 2008-07-21 PT PT08013091T patent/PT2151235E/pt unknown
- 2008-07-21 DE DE502008002621T patent/DE502008002621D1/de active Active
- 2008-07-21 DK DK08013091.7T patent/DK2151235T3/da active
- 2008-07-21 ME MEP-2011-46A patent/ME01256B/me unknown
- 2008-07-21 RS RS20110100A patent/RS51649B/sr unknown
- 2008-07-21 PL PL08013091T patent/PL2151235T3/pl unknown
- 2008-07-21 SI SI200830187T patent/SI2151235T1/sl unknown
- 2008-07-21 ES ES08013091T patent/ES2358158T3/es active Active
2009
- 2009-02-07 UA UAA201101686A patent/UA100759C2/uk unknown
- 2009-07-02 US US13/054,844 patent/US8580300B2/en not_active Expired - Fee Related
- 2009-07-02 CA CA2731312A patent/CA2731312C/en not_active Expired - Fee Related
- 2009-07-02 CN CN2009801358800A patent/CN102159196B/zh not_active Expired - Fee Related
- 2009-07-02 WO PCT/EP2009/058320 patent/WO2010009961A1/de not_active Ceased
- 2009-07-02 EP EP09800023A patent/EP2306988B1/de not_active Revoked
- 2009-07-02 HR HRP20130171AT patent/HRP20130171T1/hr unknown
- 2009-07-02 NZ NZ590593A patent/NZ590593A/en unknown
- 2009-07-02 ME MEP-2013-22A patent/ME01494B/me unknown
- 2009-07-02 PT PT98000235T patent/PT2306988E/pt unknown
- 2009-07-02 DK DK09800023.5T patent/DK2306988T3/da active
- 2009-07-02 AU AU2009273361A patent/AU2009273361B2/en not_active Ceased
- 2009-07-02 SI SI200930502T patent/SI2306988T1/sl unknown
- 2009-07-02 ES ES09800023T patent/ES2399321T3/es active Active
- 2009-07-02 RS RS20130071A patent/RS52662B/sr unknown
- 2009-07-02 PL PL09800023T patent/PL2306988T3/pl unknown
- 2009-07-02 JP JP2011519101A patent/JP5616889B2/ja not_active Expired - Fee Related
- 2009-07-02 EA EA201100229A patent/EA018465B1/ru not_active IP Right Cessation
2011
- 2011-01-11 ZA ZA2011/00283A patent/ZA201100283B/en unknown
- 2011-01-20 IL IL210779A patent/IL210779A/en active IP Right Grant
- 2011-03-11 CY CY20111100274T patent/CY1111878T1/el unknown
- 2011-03-23 HR HR20110208T patent/HRP20110208T1/hr unknown
2013
- 2013-02-26 CY CY20131100174T patent/CY1113719T1/el unknown
- 2013-10-23 US US14/061,578 patent/US20140079646A1/en not_active Abandoned
2014
- 2014-07-30 JP JP2014155149A patent/JP6209495B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL210779A0 (en)	2011-03-31
ES2399321T3 (es)	2013-03-27
EA018465B1 (ru)	2013-08-30
ME01256B (me)	2013-06-20
ATE498396T1 (de)	2011-03-15
EP2306988A1 (de)	2011-04-13
ES2358158T3 (es)	2011-05-06
AU2009273361A1 (en)	2010-01-28
CY1111878T1 (el)	2015-11-04
PL2151235T3 (pl)	2011-05-31
JP2014221827A (ja)	2014-11-27
JP6209495B2 (ja)	2017-10-04
HRP20110208T1 (hr)	2011-04-30
SI2306988T1 (sl)	2013-03-29
CA2731312C (en)	2016-05-10
RS51649B (sr)	2011-10-31
WO2010009961A1 (de)	2010-01-28
US8580300B2 (en)	2013-11-12
SI2151235T1 (sl)	2011-04-29
EP2151235A1 (de)	2010-02-10
UA100759C2 (uk)	2013-01-25
US20110123460A1 (en)	2011-05-26
EA201100229A1 (ru)	2011-08-30
HRP20130171T1 (hr)	2013-03-31
ME01494B (me)	2014-04-20
CY1113719T1 (el)	2016-06-22
AU2009273361B2 (en)	2014-03-20
HK1149907A1 (en)	2011-10-21
US20140079646A1 (en)	2014-03-20
CN102159196B (zh)	2013-05-08
EP2306988B1 (de)	2013-01-09
ZA201100283B (en)	2011-10-26
JP2011528679A (ja)	2011-11-24
CA2731312A1 (en)	2010-01-28
CN102159196A (zh)	2011-08-17
NZ590593A (en)	2012-07-27
DK2151235T3 (da)	2011-04-11
DE502008002621D1 (de)	2011-03-31
IL210779A (en)	2015-07-30
PT2151235E (pt)	2011-03-21
RS52662B (sr)	2013-06-28
JP5616889B2 (ja)	2014-10-29
DK2306988T3 (da)	2013-03-18
PT2306988E (pt)	2013-02-15
EP2151235B1 (de)	2011-02-16

Publication	Publication Date	Title
IL210779A0 (en)	2011-03-31	Pharmaceutical formulation for treating the upper digestive tract
AR114143A2 (es)	2020-07-29	Formulaciones de comprimidos revestidos
EP2440210A4 (en)	2014-01-29	METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
WO2009064460A3 (en)	2009-07-30	Gastrointestinal delivery systems
WO2010127099A3 (en)	2014-03-20	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2011112229A3 (en)	2011-11-24	Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2008028193A3 (en)	2008-12-04	Colon-targeted oral formulations of cytidine analogs
MX2010009222A (es)	2010-09-28	Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
WO2012083017A3 (en)	2012-08-23	Controlled release oral dosage forms of poorly soluble drugs and uses thereof
WO2009111611A3 (en)	2010-03-04	Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
FR2953142B1 (fr)	2013-04-12	Appareil de delivrance regulee d'un gaz,notamment appareil d'assistance respiratoire
TN2012000279A1 (en)	2013-12-12	Processes for the manufacture of a pharmaceutically active agent
WO2011072069A3 (en)	2011-11-17	Gastric retentive pharmaceutical compositions for extended release of polypeptides
DE502008002255D1 (de)	2011-02-24	Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
WO2010081722A3 (en)	2010-09-23	Orally disintegrating tablets for the treatment of pain
WO2010148314A3 (en)	2011-05-26	Preparation of esomeprazole and its pharmaceutically acceptable salts
WO2007115286A3 (en)	2008-04-17	Combinations of therapeutic agents for treating cancer
WO2012064130A3 (ko)	2012-07-19	대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
IL207977A0 (en)	2010-12-30	Therapy for disorders of the proximal digestive tract
WO2011002814A3 (en)	2011-05-26	Sulfonamido - biphenyloxyacetic acid compounds
SI2344166T1 (sl)	2013-04-30	Farmacevtska sestava za zdravljenje gastrointestinalnih iritacij
WO2007138577A3 (en)	2009-04-23	Methods of generating a neural tissue using muscle-derived cells
WO2011161465A3 (en)	2012-08-23	Composition for treatment of skin
UA96289C2 (ru)	2011-10-25	Способ получения лекарственного средства на основе ингибитора протеаз распылительной сушкой (варианты) и препарат (варианты)
UA38368U (ru)	2009-01-12	Лечебно-профилактический фитосироп "иммуностимулин"